ZBH Zimmer Biomet Holdings Inc

Price (delayed)

$161.01

Market cap

$33.37B

P/E Ratio

N/A

Dividend/share

$0.96

EPS

-$0.73

Enterprise value

$40.7B

Sector: Healthcare
Industry: Medical Devices

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights

ZBH's quick ratio has soared by 132% YoY and by 24% QoQ
The net income has dropped by 68% year-on-year
The EPS has plunged by 52% YoY

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
207.28M
Market cap
$33.37B
Enterprise value
$40.7B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.81
Price to sales (P/S)
4.72
EV/EBIT
1,432.99
EV/EBITDA
38.77
EV/Sales
5.76
Earnings
Revenue
$7.06B
EBIT
$28.4M
EBITDA
$1.05B
Free cash flow
$761.9M
Per share
EPS
-$0.73
Free cash flow per share
$3.68
Book value per share
$57.34
Revenue per share
$34.11
TBVPS
$39.29
Balance sheet
Total assets
$24.03B
Total liabilities
$12.15B
Debt
$8.29B
Equity
$11.87B
Working capital
$2.89B
Liquidity
Debt to equity
0.7
Current ratio
2.27
Quick ratio
1.02
Net debt/EBITDA
6.98
Margins
EBITDA margin
14.9%
Gross margin
70.8%
Net margin
-2.2%
Operating margin
0.1%
Efficiency
Return on assets
-0.6%
Return on equity
-1.3%
Return on invested capital
0.2%
Return on capital employed
0.1%
Return on sales
0.4%
Dividend
Dividend yield
0.6%
DPS
$0.96
Payout ratio
N/A

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
-1.2%
1 week
0.56%
1 month
6.75%
1 year
6.64%
YTD
4.49%
QTD
4.49%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.06B
Gross profit
$5B
Operating income
$8.3M
Net income
-$151.9M
Gross margin
70.8%
Net margin
-2.2%
Zimmer Biomet Holdings's operating income has surged by 118% QoQ but it has decreased by 19% YoY
Zimmer Biomet Holdings's operating margin has surged by 117% QoQ
The net margin has dropped by 100% year-on-year
The net income has dropped by 68% year-on-year

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
P/E
N/A
P/B
2.81
P/S
4.72
EV/EBIT
1,432.99
EV/EBITDA
38.77
EV/Sales
5.76
The EPS has plunged by 52% YoY
The stock's P/B is 28% above its 5-year quarterly average of 2.2 and 28% above its last 4 quarters average of 2.2
ZBH's price to sales (P/S) is 48% higher than its 5-year quarterly average of 3.2 and 35% higher than its last 4 quarters average of 3.5
The revenue has contracted by 11% YoY

Efficiency

How efficient is Zimmer Biomet Holdings business performance
The ROS has soared by 180% from the previous quarter
The ROIC has soared by 167% QoQ
Zimmer Biomet Holdings's return on equity has shrunk by 63% YoY
The ROA has plunged by 50% YoY

Dividends

What is ZBH's dividend history
DPS
$0.96
Dividend yield
0.6%
Payout ratio
N/A
Recent dividends

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 98% higher than the total liabilities
ZBH's quick ratio has soared by 132% YoY and by 24% QoQ
The current ratio has soared by 94% YoY and by 4.1% from the previous quarter
The debt is 30% smaller than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.